Based on results from two recent clinical trials, the US Food and Drug Administration approves ubrogepant for short-term migraine treatment.
-
-
The IASP Global Alliance of Pain Patient Advocates (GAPPA): Incorporating the Lived Experience of Pain into the Study of Pain
In this invited op-ed, Joletta Belton and Blair Smith, co-chairs of GAPPA, discuss a new initiative aiming to advance pain research and care by incorporating the perspectives of people who have lived with or have been affected by pain.
-
A New Clinical Trial Shows Clear Benefits of TENS for Fibromyalgia – Finally!
Transcutaneous electrical nerve stimulation reduces pain from movement and fatigue.
-
The Culture of Research: “A Shocking Portrait” Calls for Immediate Change
A Wellcome Trust study documents a plethora of widespread issues, including career insecurity, bullying and harassment, sexism and mental health issues. Pain investigators said these problems apply to the pain research environment too.
-
Multidisciplinary Pain Care: A Teamwork Approach with the Patient Front and Center
Experts say having a diverse group of healthcare professionals, working with patients who feel empowered to manage their own condition, is the best way forward to tackle the problem of chronic pain.